Successful treatment of quintuple primary cancer, including esophageal cancer: A case report

Otowa,Yasunori; Nakamura,Tetsu; Takiguchi,Gosuke; Urakawa,Naoki; Ishida,Ryo; Imanishi,Tatsuya; Suzuki,Satoshi; Tanaka,Kenichi; Kuroda,Daisuke; Kakeji,Yoshihiro

doi:10.3892/ol.2015.3082

Successful treatment of quintuple primary cancer, including esophageal cancer: A case report

Authors:
- Yasunori Otowa
- Tetsu Nakamura
- Gosuke Takiguchi
- Naoki Urakawa
- Ryo Ishida
- Tatsuya Imanishi
- Satoshi Suzuki
- Kenichi Tanaka
- Daisuke Kuroda
- Yoshihiro Kakeji
View Affiliations

Affiliations: Department of Surgery, Division of Gastrointestinal Surgery, Kobe University Graduate School of Medicine, Kobe, Japan, Department of Surgery, Kita‑Harima Medical Center, Ono, Hyogo, Japan
Published online on: March 27, 2015 https://doi.org/10.3892/ol.2015.3082
Pages: 2583-2585

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study reports the rare case of a patient with quintuple primary cancer that underwent systematic treatment, including surgical intervention. A 63‑year‑old male patient was initially diagnosed with primary esophageal cancer and hypopharyngeal cancer. The patient underwent total pharyngolaryngoesophagectomy using a thoracoscopic method and reconstruction using the free jejunal flap and gastric tube and was subsequently administered adjuvant chemotherapy (80 mg/m2 intravenously on day 1, cisplatin; 800 mg/m2 continuous intravenous administration on days 1-5, 5‑fluorouracil). At 66 years old, the patient was diagnosed with left maxillary sinus cancer and underwent chemoradiotherapy (four 100 mg/m2 arterial cisplatin injections; 70 Gy/35 f radiotherapy, 2 Gy per day over 35 days). At 68 years old, the patient was diagnosed with gastric tube cancer and underwent gastric tube resection followed by pedicled jejunum flap reconstruction. At 69 years old, the patient was diagnosed with tongue cancer and underwent resection and reconstruction of the tongue by pectoralis major myocutaneous flap. Six years subsequent to the primary surgery, the patient remains alive, without metastasis of the lesions. To the best of our knowledge, the present study is the first report of a patient that underwent a curative procedure for the treatment of five primary multiple cancers in five organs, including esophageal cancer.

View Figures

View References

1	Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Bouvard V, Altieri A and Cogliano V: WHO International Agency for Research on Cancer Monograph Working Group: Carcinogenicity of alcoholic beverages. Lancet Oncol. 8:292–293. 2007. View Article : Google Scholar : PubMed/NCBI
2	American Cancer Society: Cancer Facts & Figures 2015American Cancer Society; Atlanta, GA, USA: 2015
3	Jemal A, Bray F, Center MM, et al: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
4	Ries LAG, Harkins D, Krapcho M, et al: SEER Cancer Statistics Review, 1975–2003National Cancer Institute; Bethesda, MD: 2006
5	Tachimori Y, Ozawa S, Fujishiro M, et al: Comprehensive registry of esophageal cancer in Japan, 2006. Esophagus. 11:21–47. 2014. View Article : Google Scholar
6	Belcher R, Hayes K, Fedewa S and Chen AY: Current treatment of head and neck squamous cell cancer. J Surg Oncol. 110:551–574. 2014. View Article : Google Scholar : PubMed/NCBI
7	Sabesan A, Petrelli NJ and Bennett JJ: Outcomes of gastric cancer resections performed in a high volume community cancer center. Surg Oncol. Nov 14–2014.(Epub ahead of print). PubMed/NCBI
8	Cercato MC, Colella E, Ferraresi V, Diodoro MG and Tonachella R: Report of two cases of quintuple primary malignancies and review of the literature. Anticancer Res. 28((5B)): 2953–2958. 2008.PubMed/NCBI
9	Sobin LH, Gospodarowicz MK and Wittekind C: Digestive system tumorsInternational Union Against Cancer: TNM Classification of Malignant Tumours. 6th. Wiley-Liss; New York: pp. 60–64. 2002
10	Eisenhauer EA, Therasse P, Bogaerts J, et al: New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247. 2009. View Article : Google Scholar : PubMed/NCBI
11	Pohl H, Sirovich B and Welch HG: Esophageal adenocarcinoma incidence: Are we reaching the peak? Cancer Epidemiol Biomarkers Prev. 19:1468–1470. 2010. View Article : Google Scholar : PubMed/NCBI
12	Morita M, Yoshida R, Ikeda K, Egashira A, Oki E, Sadanaga N, Kakeji Y, Yamanaka T and Maehara Y: Advances in esophageal cancer surgery in Japan: An analysis of 1000 consecutive patients treated at a single institute. Surgery. 143:499–508. 2008. View Article : Google Scholar : PubMed/NCBI
13	Chuang SC, Hashibe M, Scelo G, et al: Risk of second primary cancer among esophageal cancer patients: A pooled analysis of 13 cancer registries. Cancer Epidemiol Biomarkers Prev. 17:1543–1549. 2008. View Article : Google Scholar : PubMed/NCBI
14	Weaver A, Fleming SM, Knechtges TC and Smith D: Triple endoscopy: A neglected essential in head and neck cancer. Surgery. 86:493–496. 1979.PubMed/NCBI
15	Sugimachi K, Ohno S, Matsuda H, Mori M and Kuwano H: Lugol-combined endoscopic detection of minute malignant lesions of the thoracic esophagus. Ann Surg. 208:179–183. 1988. View Article : Google Scholar : PubMed/NCBI
16	Nonaka S, Saito Y, Oda I, Kozu T and Saito D: Narrow-band imaging endoscopy with magnification is useful for detecting metachronous superficial pharyngeal cancer in patients with esophageal squamous cell carcinoma. J Gastroenterol Hepatol. 25:264–269. 2010. View Article : Google Scholar : PubMed/NCBI
17	Morita M, Kawano H, Otsu H, et al: Surgical resection for esophageal cancer synchronously or metachronously associated with head and neck cancer. Ann Surg Oncol. 20:2434–2439. 2013. View Article : Google Scholar : PubMed/NCBI
18	Okabayashi K, Ashrafian H, Zacharakis E, Hasegawa H, Kitagawa Y, Athanasiou T and Darzi A: Adhesions after abdominal surgery: A systematic review of the incidence, distribution and severity. Surg Today. 44:405–420. 2014. View Article : Google Scholar : PubMed/NCBI
19	van der Hoop RG, van der Burg ME, ten Bokkel Huinink WW, van Houwelingen C and Neijt JP: Incidence of neuropathy in 395 patients with ovarian cancer treated with or without cisplatin. Cancer. 66:1697–1702. 1990. View Article : Google Scholar : PubMed/NCBI
20	Guerrero Urbano MT and Nutting CM: Clinical use of intensity-modulated radiotherapy: Part I. Br J Radiol. 77:88–96. 2004. View Article : Google Scholar : PubMed/NCBI